Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do plasma melatonin concentrations decline with age?

J M Zeitzer1, J E Daniels, J F Duffy

  • 1Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

The American Journal of Medicine
|November 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid suppression of bone formation marker in response to sleep restriction and circadian disruption in men.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same author

24-hour profile of serum sclerostin and its association with bone biomarkers in men.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

Do sleep disturbances mediate the association between work-family conflict and depressive symptoms among nurses? A cross-sectional study.

Journal of psychiatric and mental health nursing·2017
Same author

Circadian regulation of sleep propensity, sleep structure and alertness: A symphony of paradoxes.

Acta neuropsychiatrica·2016
Same author

Mammalian rest/activity patterns explained by physiologically based modeling.

PLoS computational biology·2013
Same author

Arousal state feedback as a potential physiological generator of the ultradian REM/NREM sleep cycle.

Journal of theoretical biology·2012

This study found no significant difference in plasma melatonin levels between healthy older and younger adults. These findings challenge the idea that melatonin naturally declines with age and suggest caution before using melatonin supplements in older individuals.

Area of Science:

  • Endocrinology
  • Gerontology
  • Sleep Medicine

Background:

  • Previous research suggested that melatonin, a sleep-promoting hormone, decreases with age.
  • This led to recommendations for melatonin replacement therapy for sleep issues in older adults.
  • A reassessment was needed to verify age-related changes in melatonin secretion.

Purpose of the Study:

  • To investigate whether the endogenous circadian rhythm of plasma melatonin concentration changes with age in healthy, drug-free adults.
  • To compare melatonin profiles in older and younger healthy individuals.

Main Methods:

  • Analyzed plasma melatonin profiles during a constant routine in 34 healthy older adults (65-81 years).
  • Compared these profiles with those of 98 healthy young men (18-30 years).
Keywords:
NASA Discipline Regulatory PhysiologyNASA Program Biomedical Research and CountermeasuresNon-NASA Center

Related Experiment Videos

  • Assessed parameters including 24-hour average concentration, duration, mean, and integrated area of the nocturnal melatonin peak.
  • Main Results:

    • No significant difference was found in the endogenous circadian amplitude of plasma melatonin rhythm between older and younger healthy adults.
    • Key melatonin parameters (24-hour average, duration, mean, nocturnal peak area) showed no significant age-related decline.
    • Specific values: Mean 24-hour average melatonin (70 pmol/L vs 73 pmol/L, P=0.97); Duration (9.3h vs 9.1h, P=0.43).

    Conclusions:

    • The study's results do not support the hypothesis that reduced plasma melatonin is a general characteristic of healthy aging.
    • Clinical use of melatonin replacement therapy or supplementation in older patients should be preceded by an assessment of their endogenous melatonin levels.
    • This approach ensures appropriate treatment decisions for sleep disturbances in the elderly.